Skip to main content
. Author manuscript; available in PMC: 2023 Jul 17.
Published in final edited form as: Vaccine. 2022 Feb 10;40(12):1810–1820. doi: 10.1016/j.vaccine.2022.02.006

Table 1.

Comparison of demographic characteristics and vaccination status of children selected for the vaccine-preventable disease serosurvey by diphtheria-tetanus antibody testing status and survey site — Ukraine, 2017

Characteristics Tested for diphtheria and tetanus antibodies Not tested (refused or not enough sample) P value, tested versus not tested
No. % of all children No. % of all children
Zakarpattya
Total children 1,306 100.0 275 100.0 n/a
 Born in 2006–2010 790 60.5 138 50.2 0.002
 Female 613 46.9 129 46.9 0.994
 Received <3 doses of DTCV 313 24.0 98 35.6 <0.001
Sumy
Total children 1,403 100.0 190 100.0 n/a
 Born in 2006–2010 835 59.5 102 53.7 0.128
 Female 674 48.0 102 53.7 0.145
 Received <3 doses of DTCV 261 18.6 118 62.1 <0.001
Odessa
Total children 1,298 100.0 236 100.0 n/a
 Born in 2006–2010 781 60.2 117 49.6 0.003
 Female 628 48.4 124 52.5 0.240
 Received <3 doses of DTCV 234 18.0 83 35.2 <0.001
Kyiv City
Total children 722 100.0 77 100.0 n/a
 Born in 2006–2010 442 61.2 33 42.9 0.002
 Female 353 48.9 32 41.6 0.224
 Received <3 doses of DTCV 86 11.9 17 22.1 0.018

Note: Doses of any diphtheria-tetanus-containing vaccines (DTCV) are included. Immunization information reflects the status as of July–August 2017, prior to the survey specimen collection in late August–September 2017; n/a – not applicable